Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1 + NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells

Journal of Immunology

Volumn 182, Issue 11, 2009, Pages 6727-6735

  Morvan, Maelig ^a   Willem, Catherine ^a   Gagne, Katia ^a,b   Kerdudou, Nolwenn ^a   David, Gaelle ^a   Sébille, Véronique ^c   Folléa, Gilles ^a   Bignon, Jean Denis ^a,b   Retière, Christelle ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Universite de Nantes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS1; POLYINOSINIC POLYCYTIDYLIC ACID; HLA BW4; HLA-BW4; KIR3DL1 PROTEIN, HUMAN;

ADULT; ALLOGENEIC RESTRICTION; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CELL STRAIN K 562; CONTROLLED STUDY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOTOXICITY; MICROENVIRONMENT; NATURAL KILLER CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN MOTIF; TARGET CELL DESTRUCTION; CELL PROLIFERATION; CYTOLOGY; CYTOTOXICITY; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; NATURAL KILLER T CELL; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

CELL PROLIFERATION; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HLA-B ANTIGENS; HUMANS; K562 CELLS; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1; T-LYMPHOCYTE SUBSETS;

EID: 67449116287     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900212     Document Type: Article

References (55)

1. Ljunggren, H. G., and K. Karre. 1990. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol. Today 11: 237-244.
2. Ruggeri, L., M. Capanni, M. Casucci, I. Volpi, A. Tosti, K. Perruccio, E. Urbani, R. S. Negrin, M. F. Martelli, and A. Velardi. 1999. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 94: 333-339. (Pubitemid 29300166)
3. Ruggeri, L., M. Capanni, E. Urbani, K. Perruccio, W. D. Shlomchik, A. Tosti, S. Posati, D. Rogaia, F. Frassoni, F. Aversa, M. F. Martelli, and A. Velardi. 2002. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295: 2097-2100.
4. Bignon, J. D., and K. Gagne. 2005. KIR matching in hematopoietic stem cell transplantation. Curr. Opin. Immunol. 17: 553-559.
5. Bottino, C., L. Moretta, D. Pende, M. Vitale, and A. Moretta. 2004. Learning how to discriminate between friends and enemies, a lesson from natural killer cells. Mol. Immunol. 41: 569-575.
6. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
7. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633.
8. Trowsdale, J., R. Barten, A. Haude, C. A. Stewart, S. Beck, and M. J. Wilson. 2001. The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181: 20-38.
9. Vivier, E., and M. Daeron. 1997. Immunoreceptor tyrosine-based inhibition motifs. Immunol. Today 18: 286-291.
10. Vely, F., and E. Vivier. 1997. Conservation of structural features reveals the existence of a large family of inhibitory cell surface receptors and noninhibitory/activatory counterparts. J. Immunol. 159: 2075-2077. (Pubitemid 127680992)
11. Gardiner, C. M., L. A. Guethlein, H. G. Shilling, M. Pando, W. H. Carr, R. Rajalingam, C. Vilches, and P. Parham. 2001. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J. Immunol. 166: 2992-3001.
12. Pando, M. J., C. M. Gardiner, M. Gleimer, K. L. McQueen, and P. Parham. 2003. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 171: 6640-6649.
13. Yawata, M., N. Yawata, M. Draghi, A. M. Little, F. Partheniou, and P. Parham. 2006. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203: 633-645.
14. Gumperz, J. E., V. Litwin, J. H. Phillips, L. L. Lanier, and P. Parham. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133-1144.
15. Thananchai, H., G. Gillespie, M. P. Martin, A. Bashirova, N. Yawata, M. Yawata, P. Easterbrook, D. W. McVicar, K. Maenaka, P. Parham, et al. 2007. Cutting Edge: Allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178: 33-37.
16. + HLA-B with KIR3DL1. J. Immunol. 181: 6293-6300.
17. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229.
18. Cella, M., A. Longo, G. B. Ferrara, J. L. Strominger, and M. Colonna. 1994. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180: 1235-1242.
19. Parham, P. 2006. Taking license with natural killer cell maturation and repertoire development. Immunol. Rev. 214: 155-160.
20. + HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations. Blood 112: 435-443.
21. Kim, S., J. B. Sunwoo, L. Yang, T. Choi, Y. J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105: 3053-3058.
22. + T cell epitopes. AIDS Res. Hum. Retrovir. 23: 451-455.
23. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874.
24. Lopez-Vazquez, A., L. Rodrigo, J. Martinez-Borra, R. Perez, M. Rodriguez, J. L. Fdez-Morera, D. Fuentes, S. Rodriguez-Rodero, S. Gonzaez, and C. Lopez-Larrea. 2005. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J. Infect. Dis. 192: 162-165.
25. Arnheim, L., J. Dillner, and C. B. Sanjeevi. 2005. A population-based cohort study of KIR genes and genotypes in relation to cervical intraepithelial neoplasia. Tissue Antigens 65: 252-259.
26. Carrington, M., S. Wang, M. P. Martin, X. Gao, M. Schiffman, J. Cheng, R. Herrero, A. C. Rodriguez, R. Kurman, R. Mortel, et al. 2005. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J. Exp. Med. 201: 1069-1075.
27. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
28. Qi, Y., M. P. Martin, X. Gao, L. Jacobson, J. J. Goedert, S. Buchbinder, G. D. Kirk, S. J. O'Brien, J. Trowsdale, and M. Carrington. 2006. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2: e79.
29. Carrington, M., M. P. Martin, and J. van Bergen. 2008. KIR-HLA intercourse in HIV disease. Trends Microbiol. 16: 620-627.
30. Carr, W. H., D. B. Rosen, H. Arase, D. F. Nixon, J. Michaelsson, and L. L. Lanier. 2007. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178: 647-651.
31. O'Connor, G. M., K. J. Guinan, R. T. Cunningham, D. Middleton, P. Parham, and C. M. Gardiner. 2007. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178: 235-241. (Pubitemid 46033606)
32. Pascal, V., E. Yamada, M. P. Martin, G. Alter, M. Altfeld, J. A. Metcalf, M. W. Baseler, J. W. Adelsberger, M. Carrington, S. K. Anderson, and D. W. McVicar. 2007. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J. Immunol. 179: 1625-1633.
33. Trundley, A., H. Frebel, D. Jones, C. Chang, and J. Trowsdale. 2007. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 37: 780-787.
34. Ravet, S., D. Scott-Algara, E. Bonnet, H. K. Tran, T. Tran, N. Nguyen, L. X. Truong, I. Theodorou, F. Barre-Sinoussi, G. Pancino, and P. Paul. 2007. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood. 109: 4296-4305.
35. Alter, G., M. P. Martin, N. Teigen, W. H. Carr, T. J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, C. Brander, et al. 2007. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204: 3027-3036.
36. Morvan, M., G. David, V. Sebille, A. Perrin, K. Gagne, C. Willem, N. Kerdudou, L. Denis, B. Clemenceau, G. Follea, J. D. Bignon, and C. Retiere. 2008. Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions. Eur. J. Immunol. 38: 3474-3486.
37. Miller, S. A., D. D. Dykes, and H. F. Polesky. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16: 1215.
38. Marsh, S. G., P. Parham, B. Dupont, D. E. Geraghty, J. Trowsdale, D. Middleton, C. Vilches, M. Carrington, C. Witt, L. A. Guethlein, et al. 2003. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Tissue Antigens 62: 79-86.
39. Denis, L., J. Sivula, P. A. Gourraud, N. Kerdudou, R. Chout, C. Ricard, J. P. Moisan, K. Gagne, J. Partanen, and J. D. Bignon. 2005. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66: 267-276.
40. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, L. L. Lanier, and A. J. McMichael. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
41. + to post-genomics meta-analyses. Curr. Opin. Immunol. 19: 365-372.
42. Barbour, J. D., U. Sriram, S. J. Caillier, J. A. Levy, F. M. Hecht, and J. R. Oksenberg. Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3: e43, 2007.
43. Boulet, S., S. Sharafi, N. Simic, J. Bruneau, J. P. Routy, C. M. Tsoukas, and N. F. Bernard. 2008. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22: 595-599.
44. Long, B. R., L. C. Ndhlovu, J. R. Oksenberg, L. L. Lanier, F. M. Hecht, D. F. Nixon, and J. D. Barbour. 2008. Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection. J. Virol. 82: 4785-4792.
45. Goodridge, J. P., L. J. Lathbury, N. K. Steiner, C. N. Shulse, P. Pullikotil, N. G. Seidah, C. K. Hurley, F. T. Christiansen, and C. S. Witt. 2007. Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells. Eur. J. Immunol. 37: 199-211.
46. Gaudieri, S., D. DeSantis, E. McKinnon, C. Moore, D. Nolan, C. S. Witt, S. A. Mallal, and F. T. Christiansen. 2005. Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 6: 683-690.
47. Norman, P. J., L. Abi-Rached, K. Gendzekhadze, D. Korbel, M. Gleimer, D. Rowley, D. Bruno, C. V. Carrington, D. Chandanayingyong, Y. H. Chang, et al. 2007. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat. Genet. 39: 1092-1099.
48. Single, R. M., M. P. Martin, X. Gao, D. Meyer, M. Yeager, J. R. Kidd, K. K. Kidd, and M. Carrington. 2007. Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 39: 1114-1119.
49. Kulkarni, S., R. M. Single, M. P. Martin, R. Rajalingam, R. Badwe, N. Joshi, and M. Carrington. 2008. Comparison of the rapidly evolving KIR locus in Parsis and natives of India. Immunogenetics 60: 121-129.
50. Middleton, D., L. Menchaca, H. Rood, and R. Komerofsky. 2003. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61: 403-407.
51. Thananchai, H., T. Makadzange, K. Maenaka, K. Kuroki, Y. Peng, C. Conlon, S. Rowland-Jones, and T. Dong. 2009. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells. AIDS. 23: 189-193.
52. Hansasuta, P., T. Dong, H. Thananchai, M. Weekes, C. Willberg, H. Aldemir, S. Rowland-Jones, and V. M. Braud. 2004. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34: 1673-1679.
53. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
54. Smith, H. R., J. W. Heusel, I. K. Mehta, S. Kim, B. G. Dorner, O. V. Naidenko, K. Iizuka, H. Furukawa, D. L. Beckman, J. T. Pingel, et al. 2002. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc. Natl. Acad. Sci. USA 99: 8826-8831.
55. Katz, G., R. Gazit, T. I. Arnon, T. Gonen-Gross, G. Tarcic, G. Markel, R. Gruda, H. Achdout, O. Drize, S. Merims, and O. Mandelboim. 2004. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J. Immunol. 173: 1819-1825. (Pubitemid 38971615)